SLC23A2 and Alzheimer disease: Given that AD is a disease of the brain and its primary region of neurological impact is the hippocampus, we aimed to determine the status of SVCT2 (SVCT2 is mainly expressed in brain [9,14]) protein and mRNA expression in the 5XFAD mouse hippocampus.